These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35679369)

  • 21. In Situ Expansion, Differentiation, and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid.
    Kupfer ME; Lin WH; Ravikumar V; Qiu K; Wang L; Gao L; Bhuiyan DB; Lenz M; Ai J; Mahutga RR; Townsend D; Zhang J; McAlpine MC; Tolkacheva EG; Ogle BM
    Circ Res; 2020 Jul; 127(2):207-224. PubMed ID: 32228120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering spatial-organized cardiac organoids for developmental toxicity testing.
    Hoang P; Kowalczewski A; Sun S; Winston TS; Archilla AM; Lemus SM; Ercan-Sencicek AG; Gupta AR; Liu W; Kontaridis MI; Amack JD; Ma Z
    Stem Cell Reports; 2021 May; 16(5):1228-1244. PubMed ID: 33891865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-emergence of cardiac and gut tissues promotes cardiomyocyte maturation within human iPSC-derived organoids.
    Silva AC; Matthys OB; Joy DA; Kauss MA; Natarajan V; Lai MH; Turaga D; Blair AP; Alexanian M; Bruneau BG; McDevitt TC
    Cell Stem Cell; 2021 Dec; 28(12):2137-2152.e6. PubMed ID: 34861147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human pluripotent stem cell-derived lung organoids: Potential applications in development and disease modeling.
    Tian L; Gao J; Garcia IM; Chen HJ; Castaldi A; Chen YW
    Wiley Interdiscip Rev Dev Biol; 2021 Nov; 10(6):e399. PubMed ID: 33145915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Cardiac Organoids for Modeling Genetic Cardiomyopathy.
    Filippo Buono M; von Boehmer L; Strang J; Hoerstrup SP; Emmert MY; Nugraha B
    Cells; 2020 Jul; 9(7):. PubMed ID: 32698471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro Recapitulation of Neuropsychiatric Disorders with Pluripotent Stem Cells-Derived Brain Organoids.
    Gulimiheranmu M; Li S; Zhou J
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture.
    Ergir E; Oliver-De La Cruz J; Fernandes S; Cassani M; Niro F; Pereira-Sousa D; Vrbský J; Vinarský V; Perestrelo AR; Debellis D; Vadovičová N; Uldrijan S; Cavalieri F; Pagliari S; Redl H; Ertl P; Forte G
    Sci Rep; 2022 Oct; 12(1):17409. PubMed ID: 36257968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of spatial-patterned early-developing cardiac organoids using human pluripotent stem cells.
    Hoang P; Wang J; Conklin BR; Healy KE; Ma Z
    Nat Protoc; 2018 Apr; 13(4):723-737. PubMed ID: 29543795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome engineering of stem cell organoids for disease modeling.
    Sun Y; Ding Q
    Protein Cell; 2017 May; 8(5):315-327. PubMed ID: 28102490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for constructing pluripotent stem cell- and progenitor cell-derived three-dimensional cardiac micro-tissues.
    Chu X; Wang M; Qiu X; Huang Y; Li T; Otieno E; Li N; Luo L; Xiao X
    J Biomed Mater Res A; 2022 Feb; 110(2):488-503. PubMed ID: 34397148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.
    Tzatzalos E; Abilez OJ; Shukla P; Wu JC
    Adv Drug Deliv Rev; 2016 Jan; 96():234-244. PubMed ID: 26428619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical look: Challenges in differentiating human pluripotent stem cells into desired cell types and organoids.
    Fowler JL; Ang LT; Loh KM
    Wiley Interdiscip Rev Dev Biol; 2020 May; 9(3):e368. PubMed ID: 31746148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Utility of Human Kidney Organoids in Modeling Kidney Disease.
    Przepiorski A; Crunk AE; Espiritu EB; Hukriede NA; Davidson AJ
    Semin Nephrol; 2020 Mar; 40(2):188-198. PubMed ID: 32303281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to grow a kidney: patient-specific kidney organoids come of age.
    Schmidt-Ott KM
    Nephrol Dial Transplant; 2017 Jan; 32(1):17-23. PubMed ID: 27411722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The myriad possibility of kidney organoids.
    Tian P; Lennon R
    Curr Opin Nephrol Hypertens; 2019 May; 28(3):211-218. PubMed ID: 30865165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights to Heart Development and Cardiac Disease Models Using Pluripotent Stem Cell Derived 3D Organoids.
    Pang JKS; Ho BX; Chan WK; Soh BS
    Front Cell Dev Biol; 2021; 9():788955. PubMed ID: 34926467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pluripotent stem cell-derived retinal organoids for disease modeling and development of therapies.
    Kruczek K; Swaroop A
    Stem Cells; 2020 Oct; 38(10):1206-1215. PubMed ID: 32506758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart organoids and tissue models for modeling development and disease.
    Miyamoto M; Nam L; Kannan S; Kwon C
    Semin Cell Dev Biol; 2021 Oct; 118():119-128. PubMed ID: 33775518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.